Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian Transgender Women

NCT03220152 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.

NCT NCT03220152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV in Brazilian Transgender Women
Lead sponsor
Oswaldo Cruz Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
July 10, 2017
Completion date
July 31, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, prevention